Back to search
Age ≥ 18 Years Old
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Age ≥ 18 Years Old trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Age ≥ 18 Years Old trials you may qualify forIn this study, researchers will learn more about the safety of BIIB142 and how it is processed in the body. This is the first time that researchers will learn a…
To evaluate the safety of tolvaptan in pediatric subjects with ARPKD
The reason for this study is to see if the study drug baricitinib is safe and effective in participants from 1 year to less than 18 years old with systemic juve…
The reason for this study is to see if the study drug baricitinib is safe and effective in the treatment of JIA in participants ages 1 to 17. This study is for…
The primary objective of the study was to evaluate the efficacy of 611 in Chinese Adolescents with moderate to severe atopic dermatitis.
New challenges, stressors, and a loss of support often accompany the transition from adolescence to adulthood. Not surprisingly, transitional-aged youth (TAY) b…
The purpose of this clinical trial is to measure efficacy, safety and pharmacokinetics (PK) of two LXE408 oral regimens and oral miltefosine tablets as active c…
Insulin resistance increases the risk of type 2 diabetes and cardiovascular disease, with gut dysbiosis emerging as a contributing factor. Metabolic endotoxemia…